The only manufacturer of medical products in Ukraine
It is known, that biological tissue substitutes(BTS) are considered “golden standard” in wounds treatment. BTS include allotransplants, xenoimplants, placental membranes etc.
Nowadays during treatment of different types of wounds xenotissues are widely used, especially xenoimplants from porcine derma, produced by liquid nitrogen cryoconservation and lyophilization, and are permitted for usage in medical establishments of Ukraine.
Usage of said biological covering allowed to significantly reduce the complications rate during wound treatment, shorten the treatment length and mortality from severe burn injuries.
During recent years several researches about possibility of xenotissues usage in dentistry have been made. We have investigated xenoimplants of derma, pericardium and peritoneum, produced by cryoconservation and lyophilization technologies and intended as BTS for temporary wounds covering (skin, mucous membranes, etc.); isolative membranes, used in dental implantation procedures; tissues defects substitution and strengthening.
Preclinical and clinical researches have been made. During experiments on pigs, xenotissues resorption rate has been studied: dermal layer of skin, peritoneum and pericardium during subdermal, subfascial and submuscular implantations of different thickness grafts.
Also we have studied amino-acid and microelements content, presence of biologically active substances (growth factors) in cryolyophilized xenotissues. Multiple amino acids have been discovered, such as: arginine, valine, histidine, isoleucine, leucine, lysine, threonine, phenylalanine etc., which provides some insight about polipotent biological activity of aforementioned biological substrates.
High oxidizing-reducing potential of xenosubstrare, which is related to content of amino acids, oxidizing enzymes (peroxidase, cytochromoxydase), other biological active substances, including acid mucopolysaccharides (hyaluronic acid, chondroitin-sulfuric acid, heparin), and is also caused by significant quantity of microelements. Wide content specter of microelements, such as Cuprum, Zinc, Argentum, Calcium, Iron etc., provides multivectoral biological activity of following xenosubstrates.
Therefore, acknowledging the data of microelements, amino acids, growth factors content, we can assume that cryolyophilized xenoimplants provide conditions of high plastic, metabolic and oxidizing-reducing potential and can be used for tissue regeneration correction in dentistry.
With this goal in mind at our facilities (LLC “Institute of Biomedical Technologies” Ternopil, Ukraine) in 2017, quality management system has been implemented and medical products are certified to meet the requirements of DSTU ISO 13485:2005; EN ISO 13485: 2012.
Cryolyophilized xenoimplants technological process of production is as follows: xenopatches from porcine tissues (derma, pericardium, peritoneum) are prepared right after slaughter, then cryoconservated in liquid nitrogen, lyophilized in sublimation chamber, all according to instructions. After lyophilization, xenopatches are packed, sterilized by the radiation method and contained in dry conditions at 25 C°. Shelf life of the product is up to 3 years.
Aforementioned technological process has been modified, due to the peculiarities of the requirements to dermal layer of xenoskin and peritoneum of different thickness, possibilities of their usage as membranes during gingival recessions treatment, dental implantations, and guided tissue regeneration procedures.
Membranes from lyophilized derma, pericardium and peritoneum have many positive qualities, such as: simplicity of usage, optimal wound regeneration, natural biomechanical effect, presence of solid multivectoral collagen net which provides continuous barrier function for 3-6 months.
Properties:
Dermal membrane usage indications:
Periodontology: derma can be used for guided tissue regeneration operations during periodontal treatment or gingival recessions surgeries.
Implantology:
Situation at start. Tooth 26 to be deleted
Roots have been separated for atraumatic extraction
Tooth has been extracted
Alveolus is covered with xenoderma membrane
Membrane is fixated with sutures
Peritoneum membrane usage indications:
Pericardial membrane usage indications:
Application preparations:
Product is submerged into sterile physiological saline solution for 5 minutes during room temperature. Then manually or instrumentally membrane is shaped into required form.
Membrane also can be used without previous saline solution soaking.
Main usage principles:
Implantation – is a surgical manipulation which involves placing the dental implant into bone tissues of the jaw. During planning of such operation, quantity and quality of the bone is the deciding factor. If available volume is not enough, bone tissue augmentation is required.
To provide optimal augmentation conditions, barrier membranes are being used.
Importance of their usage is associated with different regeneration speed of bone and soft tissues (connective tissue, epithelium). In case of germination of connective tissue or epithelium into the graft region, conditions for the subsequent prosthetics deteriorate.
Membrane is located between gums and bone, and separates soft tissues (periosteum, mucous membrane) from the graft or bone defect. It protects the bone from lysis by osteoclasts (which are located in periosteum) and lets bone tissue to grow freely under the membrane; performs function of separation and strengthening of bone substitutes.
Augmentation with usage of resorptive xenomembranes (derma, pericardium, peritoneum) has its advantages over unresorptive membrane utilization – additional surgical interference (to remove the membrane) is not required. The period of resorption is from 12 to 24 weeks. This is enough to create a new high-quality bone.
Membranes made of cell-less cryolyophilized xenotissues do not provoke inflammation processes and allergic reactions. Additionally, membrane performs a role of isolation, which doesn’t let external microorganisms to seep into graft area.
Usage of the membrane successfully militates bone atrophy, prevents its loss and provides good conditions for further dental implantation.
Cryolyophilized xenomembranes usage indications:
Main aspects of working with membranes:
Operation protocol: under local anesthesia, incision from mucous membrane to the bone is performed, with next detachment of mucosal membrane from periosteum. After placing of bone substitutes granules into defect area, barrier membrane (porcine xenoderma) is used to cover the former. Membrane is fixated with titan screws to the periosteum and adjacent teeth. Mucous patch is relocated to its original place and the wound is sutured.
Implant is placed into alveolus of previously extracted tooth.
Wound is covered with xenoderma membrane
Wound has been sutured
Situation after 6 months. RG-supervision
Sinus-lifting was performed
Bone material augmentation with simultaneous implants setting
Processus alveolaris is covered with lyophilized peritoneum membrane
Wound is sutured
Gingival recession is a pathological process that involves gingival margin retraction and exposure of the tooth root. Nowadays surgical method is main in the treatment of this decease. Most options of surgical treatment require usage of autotransplants (tissues from the same patient) or xenoimplants (tissues from other biological species). Guided tissue regeneration with resorbable and unresorbable membranes is the most common method.
However, protocols which include autotransplants or unresorbable membranes require additional surgical trauma, caused by autotransplant preparation or removing of the unresorbable membrane.
We have researched usage possibilities of cryolyophilized xenoimplants from porcine derma, peritoneum and pericardium as resorptive membranes during guided tissue regeneration treatment of gingival recessions.
With this goal in mind at our facilities (LLC “Institute of Biomedical Technologies” Ternopil, Ukraine) in 2017, quality management system has been implemented and medical products are certified to meet the requirements of DSTU ISO 13485:2005; EN ISO 13485: 2012.
Cryolyophilized xenoimplants technological process of production is as follows: xenopatches from porcine tissues (derma, pericardium, peritoneum) are prepared right after slaughter, then cryoconservated in liquid nitrogen, lyophilized in sublimation chamber, all according to instructions. After lyophilization, xenopatches are packed, sterilized by the radiation method and contained in dry conditions at 25 C°. Shelf life of the product is up to 3 years.
Operation protocol sample: under local anesthesia, intrafissural incision is performed, with next detachment of mucosal membrane from periosteum. Lyophilized xenotissues membrane (1mm thickness) is cut to have the same shape as the operation field. Then in is fixated to periosteum with vicryl sutures and covered with mucosal patch. Single nodule seams are used to fixate the patch. After 7 days, superficial sutures are removed.
Results: patients have been examined on 5th, 7th, 10th and 14th day and 3 months after operation. Gingival biotype thickening has been noted. Gingival attachment size was increased by 0,5-0,7 mm. These facts imply that pathological process has been stabilized and gingival recession is not progressing any further.
Summary: Cryolyophilized xenoimplants of porcine derma, pericardium and peritoneum can be successfully used as membranes during guided tissue regeneration treatment of gingival recessions.